NCT03638765View on ClinicalTrials.gov

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

PHASE1UnknownINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions

Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic

Interventions

BIOLOGICAL

DCVax-Direct

activated, autologous dendritic cells

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

Northwest Biotherapeutics

Collaborators (1)

All Listed Sponsors

collaborator

Mayo Clinic

OTHER

lead

Northwest Biotherapeutics

INDUSTRY

NCT03638765 - Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer | Biotech Hunter | Biotech Hunter